SBFMW

Sunshine Biopharma, Inc. SBFMW

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SBFMW BFRI EVOK AIM SNOA ADIL HSCS GBS APVO BNGO
6M -33.36 % 12.94 % 109.07 % -36.25 % 67.90 % -47.76 % 0.91 % -33.36 % -90.92 % -53.09 %
YTD 86.56 % -11.93 % 0.56 % -88.41 % 44.09 % -66.19 % -10.96 % -60.24 % -98.29 % -87.60 %
1Y 185.52 % 27.83 % -15.82 % -90.19 % 31.80 % -63.06 % 4.72 % -32.40 % -98.68 % -90.29 %
3Y -53.88 % -96.07 % -80.18 % -94.80 % -91.10 % -95.52 % -97.94 % -95.71 % -100.00 % -99.85 %
5Y -50.03 % -98.91 % -99.31 % -98.88 % -97.53 % -99.20 % -98.04 % -95.71 % -100.00 % -99.43 %
10Y -50.03 % -98.91 % -99.18 % -99.97 % -99.64 % -99.65 % -98.04 % -95.71 % -100.00 % -96.91 %
From the beginning -50.03 % -98.91 % -99.73 % -72.19 % -99.99 % -99.65 % -98.04 % -95.71 % -100.00 % -96.91 %

Dividend